Patents by Inventor Marie-Hélène Fouchet

Marie-Hélène Fouchet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL JAK INHIBITOR COMPOUNDS, METHODS FOR SYNTHESIZING SAME AND USE THEREOF
    Publication number: 20230382906
    Abstract: Novel compounds having formula (I) and methods of using these compounds to treat diseases, conditions, and disorders are described.
    Type: Application
    Filed: March 8, 2023
    Publication date: November 30, 2023
    Inventors: Gilles OUVRY, Branislav MUSICKI, Craig HARRIS, Claire BOUIX-PETER, Marie-Hélène FOUCHET, Nicolas GEORGE
  • Benzimidamides compounds comprising an oxaborinin ring
    Patent number: 11767333
    Abstract: The invention relates to 4-(1-hydroxy-3,4-dihydro-1H-benzo[c][1,2]oxaborinin-3-yl)benzimidamide derivatives and their use in treating diseases and conditions of the skin (for example, Netherton syndrome, rosacea, atopic dermatitis, psoriasis and itch) caused by abnormally high levels of protease activity (particularly of serine proteases such as kallikreins). In addition, the invention relates to compositions containing the derivatives and processes for their preparation.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: September 26, 2023
    Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: John Liddle, Ann Louise Walker, Gemma Victoria White, Alexis Denis, Nerina Dodic, Marie-Hélène Fouchet, Anne Bouillot
  • JAK INHIBITOR COMPOUNDS, METHOD FOR SYNTHESIZING SAME AND USE THEREOF
    Publication number: 20230279003
    Abstract: Novel compounds having formula (I) and methods of using these compounds to treat diseases, conditions, and disorders are described.
    Type: Application
    Filed: March 10, 2023
    Publication date: September 7, 2023
    Inventors: Gilles OUVRY, Branislav MUSICKI, Craig HARRIS, Claire BOUIX-PETER, Marie-Hélène FOUCHET, Nicolas GEORGE
  • Novel Benzimidamides Compounds Comprising an Oxaborinin Ring
    Publication number: 20220267357
    Abstract: The invention relates to 4-(1-hydroxy-3,4-dihydro-1H-benzo[c][1,2]oxaborinin-3-yl)benzimidamide derivatives and their use in treating diseases and conditions of the skin (for example, Netherton syndrome, rosacea, atopic dermatitis, psoriasis and itch) caused by abnormally high levels of protease activity (particularly of serine proteases such as kallikreins). In addition, the invention relates to compositions containing the derivatives and processes for their preparation.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 25, 2022
    Inventors: John LIDDLE, Ann Louise WALKER, Gemma Victoria WHITE, Alexis DENIS, Nerina DODIC, Marie-Hélène FOUCHET, Anne BOUILLOT
  • Benzimidamides compounds comprising an oxaborinin ring
    Patent number: 11352372
    Abstract: The invention relates to 4-(1-hydroxy-3,4-dihydro-1H-benzo[c][1,2]oxaborinin-3-yl)benzimidamide derivatives and their use in treating diseases and conditions of the skin (for example, Netherton syndrome, rosacea atopic dermatitis, psoriasis and itch) caused by abnormally high levels of protease activity (particularly of serine proteases such as kallikreins). In addition, the invention relates to compositions containing the derivatives and processes for their preparation.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: June 7, 2022
    Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: John Liddle, Ann Louise Walker, Gemma Victoria White, Alexis Denis, Nerina Dodic, Marie-Hélène Fouchet, Anne Bouillot